Forefront Analytics, LLC Bio N Tech Se Transaction History

Forefront Analytics, LLC

  • $212 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$72.71 - $129.54 $238,052 - $424,113
-3,274 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$57.81 - $104.17 $15,146 - $27,292
-262 Reduced 7.41%
3,274 $224,000
Q2 2020

Aug 10, 2020
BUY
$38.58 - $66.74 $136,418 - $235,992
3,536 New
3,536 $236,000

Others Institutions Holding BNTX

# of Institutions
356
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email